96 results
8-K
EX-99.3
TELA
TELA Bio Inc
21 Mar 24
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
4:15pm
of the operating principles, risks versus benefits, and hazards involved in utilizing an endoscopic approach or surgical approach is necessary
8-K
EX-1.1
szrwpscqwyoslh1
20 Apr 23
Entry into a Material Definitive Agreement
4:52pm
424B5
kvitjj3ip lzdi
20 Apr 23
Prospectus supplement for primary offering
4:06pm
424B5
xnrld7qwq83tab04xy
18 Apr 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
0462n0ukmkh541i
26 Oct 22
TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair
7:15am
8-K
EX-1.1
fcpvak
17 Aug 22
Entry into a Material Definitive Agreement
5:12pm
424B5
ytsc qnc9
17 Aug 22
Prospectus supplement for primary offering
5:10pm